General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dieterich DT et al. – After careful evaluation of an individual's benefit–risk ratio, a 72–week regimen is the preferred strategy for optimizing sustained response rates in patients who have not responded to the standard of care, provided that viral RNA is undetectable at week 12 of re–treatment.

Today in Hepatitis...keeping you current

Atazanavir-Associated Choledocholithiasis Leading to Acute Hepatitis in an HIV-Infected Adult
Annals of Pharmacotherapy, 12/03/09

Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy
Liver Transplantation, 12/03/09

Duration of hepatitis E viremia in pregnancy
International Journal of Gynecology & Obstetrics, 12/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address